Bio-Techne (TECH) EBT (2009 - 2026)

Bio-Techne's EBT history runs 18 years deep, the most recent figure standing at $71.2 million for Q1 2026.

• In Q1 2026, EBT rose 86.09% year-over-year to $71.2 million; the TTM figure through Mar 2026 stood at $60.3 million (down 60.34% YoY), while the FY2025 annual figure was $11.6 million, down 93.34% from the prior year.
• EBT was $71.2 million for Q1 2026 at Bio-Techne, up from $50.8 million in the prior quarter.
• In the past five years, EBT ranged from a high of $103.7 million in Q3 2022 to a low of -$109.7 million in Q2 2025.
• Historically, EBT has averaged $49.6 million across 5 years, with a median of $50.8 million in 2025.
• The sharpest annual moves came in 2022 and 2025: EBT surged 274.12% in 2022, then sank 456.34% in 2025.
• A 5-year view of EBT shows it stood at $66.4 million in 2022, then sank by 49.74% to $33.4 million in 2023, then grew by 28.42% to $42.9 million in 2024, then rose by 18.44% to $50.8 million in 2025, then soared by 40.25% to $71.2 million in 2026.
• The last three EBT figures came in at $71.2 million (Q1 2026), $50.8 million (Q4 2025), and $48.0 million (Q3 2025), per Business Quant data.